Robert W. Duggan
Co-Chief Executive Officer at Summit Therapeutics; Director at Pulse Biosciences. Based in Miami, Florida.
- Rank
- 33rd of 14,644
- Companies held
- 2
- Largest holding
- SMMT, 73.8% of total
- Latest SEC filing
- Nov 16, 2026
- Listed but not counted
- $5.7M
What the $8.59B is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Summit Therapeutics SMMT Common Stock | Directly | 573,883,879 | $10.71 | $6.15B | 71.6% | Form 4, Nov 16, 2026 |
| Pulse Biosciences PLSE Common Stock | Directly | 48,370,047 | $45.42 | $2.20B | 25.6% | Form 4/A, May 11, 2026 |
| Summit Therapeutics SMMT Common Stock | Through the Mahkam Zanganeh Revocable Trust, with the Spouse of Reporting Person as Trustee Reported jointly by 2 insiders; split evenly | 12,912,237 | $10.71 | $138M | 1.6% | Form 4, Nov 16, 2026 |
| Summit Therapeutics SMMT Common Stock | Through the Shaun Zanganeh Irrevocable Trust, with the Spouse of Reporting Person as Trustee Reported jointly by 2 insiders; split evenly | 5,099,888 | $10.71 | $54.6M | 0.6% | Form 4, Nov 16, 2026 |
| Pulse Biosciences PLSE Common Stock | Affiliated Company 1 | 630,109 | $45.42 | $28.6M | 0.3% | Form 4/A, May 11, 2026 |
| Pulse Biosciences PLSE Common Stock | Affiliated Company 2 | 450,189 | $45.42 | $20.4M | 0.2% | Form 4/A, May 11, 2026 |
| Summit Therapeutics SMMT Common Stock | Immediate family member of Spouse | 76,680 | $10.71 | $821K | 0.0% | Form 4, Nov 16, 2026 |
Share counts are the amounts Robert W. Duggan reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Robert W. Duggan's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Summit Therapeutics SMMT Common Stock | Through Spouse Counted on the profile of the insider who holds these shares directly | 531,000 | $10.71 | $5.7M | — | Form 4, Nov 16, 2026 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 30 | Patricia F. Elcan 10% owner, HCA Healthcare. Nashville, TN | $9.29B |
| 31 | Thomas F. Frist III Director, HCA Healthcare. Nashville, TN | $9.21B |
| 32 | Alexander C. Karp See Remarks, Palantir Technologies. Aventura, FL | $9.17B |
| 33 | Robert W. Duggan Co-Chief Executive Officer, Summit Therapeutics. Miami, FL | $8.59B |
| 34 | Matthew Prince CEO & Board Co-Chair, Cloudflare. Austin, TX | $8.56B |
| 35 | Jagtar Singh Chaudhry CEO & Chairman, Zscaler. San Jose, CA | $8.27B |
| 36 | George B. Kaiser Director, BOK Financial. Tulsa, OK | $7.86B |
Other Summit Therapeutics insiders
All SMMT insiders- Yu Xia$343MDirector. #627 overall
- Mahkam Zanganeh$199MCo-Chief Executive Officer. #793 overall
- Manmeet Soni$34.5MCOO and CFO. #3384 overall
- Ankur Dhingra$4.2MChief Financial Officer. #6864 overall
Questions
How much stock does Robert W. Duggan own?
Robert W. Duggan holds $8,586,062,116 in listed stock based on SEC filings and current prices, mostly Summit Therapeutics (SMMT). That ranks 33rd on the Stock Rich List.
Is this Robert W. Duggan's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Robert W. Duggan last buy or sell stock?
The most recent open-market trade on file is a purchase of 3,810,000 SMMT shares on Jun 12, 2026 at $13.12.